Skip to main content

Lupus

      RT @Janetbirdope: How concerned should we be for #hydroxychloroquine retinopathy. >4000 pts prospectively followed. 1
      3 years 2 months ago
      How concerned should we be for #hydroxychloroquine retinopathy. >4000 pts prospectively followed. 1/2 w RA & 15% w #SLE. New risks Asian with pericentral pattern and overall. Length of time on use and ⬆️wt based dose per day & CKD all risks. Abst#0989 #ACR21 #ACRBest @RheumNow https://t.co/XTfdQpVC7H
      RT @Yuz6Yusof: #ACR21 #Abstr0865 It’s time for T2T to achieve LLDAS in #lupus. In a study of N=2040 pts, mortality was
      3 years 2 months ago
      #ACR21 #Abstr0865 It’s time for T2T to achieve LLDAS in #lupus. In a study of N=2040 pts, mortality was 2.3% mainly due to infection. Remission off steroid was the best but only met in 14%. LLDAS-50 achieved in 48% pts and ⬇️mortality by 56% @RheumNow https://t.co/CddqMuFIOM https://t.co/g346Cbybep
      RT @Yuz6Yusof: #ACR21 #Abstr0864 How does obesity (BMI=/>30) affect #lupus outcomes? Data from Toronto showed:
      💠â¬
      3 years 2 months ago
      #ACR21 #Abstr0864 How does obesity (BMI=/>30) affect #lupus outcomes? Data from Toronto showed: 💠⬆️hs-CRP 💠No in disease activity over 3yrs 💠⬆️CV events (combination of low grade inflammation + hypertension) @RheumNow https://t.co/IBu8uNSAJi https://t.co/2aqz5e3rwi
      RT @drdavidliew: Can patient with low dx activity SLE stop HCQ, or at least try and reduce the dose?

      Not if you want to
      3 years 2 months ago
      Can patient with low dx activity SLE stop HCQ, or at least try and reduce the dose? Not if you want to avoid flares. If there are safer subgroups to try it in, we haven't found them yet (in fact higher dx activity➡️less risk ?other Rx) SLICC inception #ACR21 ABST0959 @RheumNow https://t.co/NS2V4dEGHv
      RT @KDAO2011: Keep the Hydroxychloroquine!
      SLICC cohort eval flare risk in 1460 pts who⬇️or d/c HCQ:
      👉pts in rem
      3 years 2 months ago
      Keep the Hydroxychloroquine! SLICC cohort eval flare risk in 1460 pts who⬇️or d/c HCQ: 👉pts in remission who d/c HCQ flared HR 2.77 (1.46,5.26) 👉pts in remission who⬇️dose flared HR 2.14 (1.34, 3.42) Abst#0959 #Plenary #ACR21 @rheumnow #ACRbest https://t.co/92U215s8IP
      RT @KDAO2011: Do you order EKGs in everyone starting HCQ? Do you avoid HCQ in patients with heart failure? Will these ab
      3 years 2 months ago
      Do you order EKGs in everyone starting HCQ? Do you avoid HCQ in patients with heart failure? Will these abstracts impact your practice? Click on link to read more....#ACR21 @rheumnow #HCQ https://t.co/fvUZAvNWa8
      RT @Yuz6Yusof: #ACR21 #Abstr0858 Petri reported effect of #COVID and vaccination in #lupus cohort
      💠No increase in act
      3 years 2 months ago
      #ACR21 #Abstr0858 Petri reported effect of #COVID and vaccination in #lupus cohort 💠No increase in activity post-infection 💠⬇️cutaneous activity 💠⬆️ aCL IgG and IgM post-infection, 💠No increase in SLE activity or aCL abs post-vaccination @RheumNow https://t.co/iAaIfzf33c https://t.co/hA6sk6icrs
      ×